Clinical Trials
3 trialsNCT04225026 2023-03-23
Effects of Intravenous GC4419 on the Incidence and Severity of Esophagitis Due to Chemoradiotherapy for Lung Cancer
Galera Therapeutics, Inc.
Phase 2 Terminated
NCT01322633 2014-02-20
Risk of Cancer Among Pantoprazole Users
Pfizer
Completed
NCT00081315 2007-08-21
Subcutaneous Amifostine (Ethyol®) in the Prevention of Radiochemotherapy-Induced Esophagitis and Pneumonitis in Patients With Unresectable Non-Small Cell Lung Cancer
MedImmune LLC
Phase 2 Completed